Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00595283 · ClinicalTrials.gov registry record · NA
Effectiveness of Parent-Child Interaction and Emotion Development Therapy in Treating Preschool Children With Depression
A NA study, sponsored by Washington University School of Medicine.
- Completed
- Registry status
- NA
- Development phase
- 38
- Enrollment target
NCT00595283: Completed NA study, sponsored by Washington University School of Medicine.
NCT00595283 is a NA study that has completed, run by Washington University School of Medicine. The registered enrollment target is 38 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00595283, a NA study, has completed, sponsored by Washington University School of Medicine.
- COMPLETED
- Registry status
- NA
- Development phase
- 38 participants
- Enrollment target
Study Summary
This study will evaluate the effectiveness of parent-child interaction therapy that includes an emotion development component in treating depression in preschool children.
Interventions
- BEHAVIORAL Parent Child Interaction Therapy-Emotion Development (PCIT-ED)
- BEHAVIORAL Developmental Education Parenting Intervention (DEPI)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 38 participants |
| Start Date | 2007-10 |
| Est. Completion | 2010-10 |
| Phase | NA |
What the finished NCT00595283 record still lists
NCT00595283 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 38 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower).
The record links to 0 conditions, and to 2 interventions - of which Parent Child Interaction Therapy-Emotion Development (PCIT-ED) is the first listed.
NCT00595283 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00595283 about?
NCT00595283 is a clinical study titled "Effectiveness of Parent-Child Interaction and Emotion Development Therapy in Treating Preschool Children With Depression". This study will evaluate the effectiveness of parent-child interaction therapy that includes an emotion development component in treating depression in preschool children.
What is the current status of trial NCT00595283?
This trial is currently completed. It is a NA study. The enrollment target is 38 participants. The study started on 2007-10. Estimated completion is 2010-10.
What interventions are being tested in trial NCT00595283?
The interventions under investigation include: Parent Child Interaction Therapy-Emotion Development (PCIT-ED) (BEHAVIORAL), Developmental Education Parenting Intervention (DEPI) (BEHAVIORAL).
Who is sponsoring clinical trial NCT00595283?
This trial is sponsored by Washington University School of Medicine, which has 1,502 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00595283's enrollment target sits among peer trials
38 1538th of 2000 higher than 461 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01684904 · 38 participants · NA
Proton Therapy for Esophageal Cancer
- NCT03310879 · 38 participants · Phase 2
Study of the CDK4/6 Inhibitor Abemaciclib in Solid Tumors Harboring Genetic Alterations in Genes Encoding D-Type Cyclins or Amplification of CDK4 or CDK6
- NCT03896269 · 38 participants · Phase 1
CPX-351 in Treating Patients With Relapsed or Refractory High Risk Myelodysplastic Syndrome or Chronic Myelomonocytic Leukemia
- NCT04085315 · 38 participants · Phase 1
Alisertib in Combination With Osimertinib in Metastatic EGFR-mutant Lung Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia